Fortis Healthcare Limited
FORTIS
Rang in aandelen
#3026
Established in 1996 and headquartered in Gurugram, India, Fortis Healthcare... Established in 1996 and headquartered in Gurugram, India, Fortis Healthcare Limited operates as an integrated provider of healthcare services. The company extends its offerings, which encompass secondary, tertiary, and quaternary medical care, across India, the United Arab Emirates, Sri Lanka, and other international markets. Its diverse healthcare infrastructure includes a network of hospitals, diagnostic facilities, and specialized day-care centers. Fortis delivers expertise across a broad spectrum of medical disciplines, including cardiology, cosmetic and dental sciences, dermatology, endocrinology, emergency medicine, ENT, fetal medicine, gastroenterology and hepatology, general surgery, haematology, infertility treatment, internal medicine, mental and behavioral health, nephrology, neurosurgery, neurointervention, neurology, obstetrics and gynaecology, oncology, ophthalmology, orthopedics, pediatrics, physiotherapy, plastic surgery, pulmonology, radiology, rheumatology, thoracic surgery, transplant medicine, urology, and numerous other supporting specialties. By March 31, 2022, the company managed 26 hospitals, housing approximately 4,300 operational beds, in addition to around 426 diagnostic centers and laboratories, complemented by 2,550 collection centers.
Aandeelprijs
$8.00
Marktkapitalisatie
$6.04B
Verandering (1 dag)
-1.73%
Verandering (1 jaar)
-35.85%
Land
IN
Handel Fortis Healthcare Limited (FORTIS)
Categorie
Healthcare
P/B-ratio voor Fortis Healthcare Limited (FORTIS)
P/B-ratio op October 2026 TTM: 5.61
Volgens de meest recente financiële rapporten en aandelenkoers van Fortis Healthcare Limited is de huidige P/B-ratio (TTM) 5.61. Eind 2024 had het bedrijf een P/B-ratio van 4.23.
P/B-ratiohistoriek voor Fortis Healthcare Limited van 2002 tot 2026
P/B-ratio aan het einde van elk jaar
| Jaar | P/B-ratio | Wijzigen |
|---|---|---|
| 2026 (TTM) | 5.61 | -3.76% |
| 2025 | 5.83 | 37.90% |
| 2024 | 4.23 | 55.98% |
| 2023 | 2.71 | -23.65% |
| 2022 | 3.55 | 44.44% |
| 2021 | 2.46 | 71.83% |
| 2020 | 1.43 | 7.28% |
| 2019 | 1.33 | -34.41% |
| 2018 | 2.03 | -10.20% |
| 2017 | 2.26 | -6.57% |
| 2016 | 2.42 | 7.77% |
| 2015 | 2.25 | 76.86% |
| 2014 | 1.27 | -12.70% |
| 2013 | 1.46 | -26.61% |
| 2012 | 1.98 | -31.40% |
| 2011 | 2.89 | -49.39% |
| 2010 | 5.71 | 73.01% |
| 2009 | 3.30 | -14.32% |
| 2008 | 3.85 | -65.22% |
| 2007 | 11.08 | -46.53% |
| 2006 | 20.72 | -92.72% |
| 2005 | 284.65 | -3.64% |
| 2004 | 295.40 | 31.31% |
| 2003 | 224.97 | 57.91% |
| 2002 | 142.46 | 0.00% |
P/B-ratio voor vergelijkbare bedrijven of concurrenten
| Bedrijf | P/B-ratio | Verschil in P/B-ratio | Land |
|---|---|---|---|
| -15.9433 | -384.14% |
US
|
|
| - | - |
DE
|
|
| 4.8701 | -13.20% |
US
|
|
| 9.3882 | 67.32% |
SA
|
|
| 4.6058 | -17.91% |
BR
|
